US drug maker Merck & Company had data four years ago showing that Vioxx raised the risk of heart attacks. Scientists say the studies were enough that Merck should have pulled it's anti-arthritis drug off the market in 2000. The British medical journal Lancet says Merck failed to properly analyze the information. Last month, Sen Charles Grassley (R-IA) drubbed the FDA for trying to supress government concerns over the drug's safety.
(MSNBC)
No comments:
Post a Comment